TSBP Talks

Welcome to TSBP Talks, the new podcast that brings you important Board news and updates. TSBP Talks is available to listen to on our YouTube channel or via the embedded YouTube videos in the episode show notes below.

Episodes

Listen to Episode #1 on our YouTube channel or via the embedded video below:

Show Notes

Welcome to our very first episode of TSBP Talks. We start this first episode with a review of November 2020 rule adoptions, in particular those that expanded technician duties and ratios and those that updated e-prescribing waiver regulations. E-prescribing became mandatory January 1, 2021, but there are certain exemption criteria, so we take a look at those in particular during this discussion.

We also discuss the February 2021 rule adoptions regarding drug therapy management and conditions under which pharmacists must consult the Texas PMP before dispensing certain drugs. We also talk a bit about the Board's discussion of the FDA MOU at February's meeting. The Board voted to add the MOU to the Compounding Advisory Group agenda at their upcoming meeting. You can find upcoming meeting information as it becomes available on our committees page.

We wrap this episode up with some reminders and news items:

Scams continue to target TSBP licensees by impersonating state agencies. See an example scam letter and learn how to protect your information and report telephone scammers on our website.
The rest of the pharmacist CE requirements adopted in November 2019 and May 2020 will go into effect later this year. Pharmacists can find detailed information about each of the requirements from our main pharmacist CE FAQ page.
The next TSBP Board meeting will be held Tuesday, May 11, 2020 beginning at 9am. You can find agenda information once it's posted on our Board Meetings page.

Links & resources for this episode

Rule Adoption Summaries

Board Meeting Agendas

Show Notes

Published August 24, 2021

We start our second episode with a review of the May 2021 rule adoptions. View the complete agenda for the May 2021 meeting/a>.

The adopted rules we review in this episode include:

§291.11 Concerning Operation of a Pharmacy (found in D.1.1);
a group of amendments related to the DEA 222 Form requirements (found in D.1.2.1, D.1.2.2, and D.1.2.3); and
a group of amendments concerning Schedule II controlled substance prescriptions (found in D.1.3.1 and D.1.3.2)

We then discuss recent news and updates that affect certain licensees:

The funding previously appropriated to TSBP to fund statewide integration and NarxCare through the Texas PMP was not renewed during the most recent legislative session. These funds expire beginning September 1, 2021. The Texas PMP vendor, Appriss Health, sent out information recently regarding these changes. Read their message on our Important Changes to PMP Enhancements page.

The temporary suspension of rules found on our COVID-19-related pages are also terminating September 1, 2021. All affected rules and/or portions of rules will no longer be suspended beginning September 1, 2021.

We also talk with our outgoing executive director, Allison Vordenbaumen Benz, R.Ph., M.S., who is retiring after 27 years of service with the Texas State Board of Pharmacy. Allison introduces our incoming executive director, Tim Tucker, PharmD. Learn more about Allison and Tim on their biography pages:

You can also find out more about the TSBP Board members on our Board Members page.